Search Results 2781-2790 of 36928 for oral

  1. Sarcoma - Doctors and departments - Mayo Clinic

    Ettinger, M.D., D.D.S.. Surgical Oncologist; Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Cancer treatment, Tracheostomy, Jaw surgery, Flap ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Soft tissue sarcoma, Tonsil ...

  3. Antibiotics and alcohol - Mayo Clinic

    Is it harmful to drink alcohol while taking antibiotics? Antibiotics and alcohol can cause some of the same side effects. These include stomach upset, dizziness ...

  4. A Study to Evaluate Posaconazole to Treat Genetically-defined Patients with Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the effects of oral antifungal treatment with posaconazole on disease activity and the burden of Malassezia spp. in ...

  5. Basel A. Sharaf, M.D., D.D.S. - Mayo Clinic Faculty Profiles

    Joint Appointment. Consultant, Division of Oral Diagnosis and Oral and Maxillofacial Surgery, Department of Surgery; Consultant, Department of Clinical ...

  6. Bone cancer - Doctors and departments - Mayo Clinic

    John M. Nathan, M.D., D.D.S.. Sleep Medicine Specialist; Oral and Maxillofacial Surgeon; Surgeon. Rochester, MN ...

  7. Open-Label Safety Study Of ADS-5102 In PD Patients With LID - Mayo Clinic

    This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in ...

  8. Katherine W. Arendt, M.D. - Doctors and Medical Staff - Mayo Clinic

    CoordinatorResident Oral Exam Simulation, Department of Anesthesiology and Perioperative Medicine. 2016 - present. ChairSouth Division, Department of ...

  9. Leslie J. Padrnos, M.D. - Doctors and Medical Staff - Mayo Clinic

    Oral Session ModeratorAnnual Meeting, Malignant Conditions (Myeloid) Quality of Life, Late Effects and Prognostic Factors in Myeloid Disease Session ...

  10. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    Oral prednisone ≥ 40 mg/day (or equivalent) or budesonide ≥ 9 mg/day or equivalent or beclomethasone ≥ 5 mg/day for at least 2 weeks;; Immunomodulators ...